Anyone see the rebates? Lawmakers accuse Mylan of underpaying Medicaid for EpiPen

(By Ed Silverman for STAT)

Did Mylan Pharmaceuticals misclassify EpiPen to avoid paying higher Medicaid rebates? Continue reading article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.